Karisik E, Ellington M J, Pike R, Livermore D M, Woodford N
Antibiotic Resistance Monitoring and Reference Laboratory, Centre for Infections, Health Protection Agency, London, UK.
Clin Microbiol Infect. 2006 Aug;12(8):803-6. doi: 10.1111/j.1469-0691.2006.01423.x.
Mutations can increase the ceftazidimase activity of CTX-M-3 beta-lactamase, as seen with its widespread variant CTX-M-15. This study compared the frequencies of emerging ceftazidime resistance in isogenic wild-type and hyper-mutable mutS CTX-M-3-producing Escherichia coli strains, and sequenced the mutant bla(CTX-M) alleles selected. Ceftazidime resistance emerged more readily in the hyper-mutable background than in the wild-type strain. All selected CTX-M mutants, in both the wild-type and the mutS derivatives, had single amino-acid changes at position 167, including a novel Pro167Gln substitution. These data emphasise the potential for further diversification of CTX-M enzymes.
突变可增加CTX-M-3β-内酰胺酶的头孢他啶酶活性,这在其广泛存在的变体CTX-M-15中可见。本研究比较了同基因野生型和高变异性mutS CTX-M-3产生菌大肠杆菌菌株中头孢他啶耐药性出现的频率,并对所选的突变bla(CTX-M)等位基因进行了测序。在高变异性背景下,头孢他啶耐药性比野生型菌株中更容易出现。在野生型和mutS衍生物中,所有所选的CTX-M突变体在第167位都有单氨基酸变化,包括一个新的Pro167Gln替代。这些数据强调了CTX-M酶进一步多样化的可能性。